# RDF export of group: Publication
<http://ctro/data#Publication_85374> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Publication> .
<http://ctro/data#Publication_85374> <http://www.w3.org/2000/01/rdf-schema#label> "Publication " .
<http://ctro/data#Publication_85374> <http://ctro/data#hasTitle> "A randomized , double - blind , non - inferiority trial evaluating the efficacy and safety of omarigliptin , a once - weekly DPP - 4 inhibitor , or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy ." .
<http://ctro/data#Publication_85374> <http://ctro/data#hasAuthor> "Handelsman Y" .
<http://ctro/data#Publication_85374> <http://ctro/data#hasPublicationYear> "2017" .
<http://ctro/data#Publication_85374> <http://ctro/data#hasJournal> "Curr Med Res Opin ." .
<http://ctro/data#Publication_85374> <http://ctro/data#hasPMID> "28548024" .
<http://ctro/data#Publication_85374> <http://ctro/data#describes> <http://ctro/data#ClinicalTrial_85390> .
<http://ctro/data#Publication_85374> <http://ctro/data#hasAuthor> "Lauring B" .
<http://ctro/data#Publication_85374> <http://ctro/data#hasAuthor> "Gantz I" .
<http://ctro/data#Publication_85374> <http://ctro/data#hasAuthor> "Iredale C" .
<http://ctro/data#Publication_85374> <http://ctro/data#hasAuthor> "O ' Neill EA" .
<http://ctro/data#Publication_85374> <http://ctro/data#hasAuthor> "Wei Z" .
<http://ctro/data#Publication_85374> <http://ctro/data#hasAuthor> "Suryawanshi S" .
<http://ctro/data#Publication_85374> <http://ctro/data#hasAuthor> "Kaufman KD" .
<http://ctro/data#Publication_85374> <http://ctro/data#hasAuthor> "Engel SS" .
<http://ctro/data#Publication_85374> <http://ctro/data#hasAuthor> "Lai E" .
# RDF export of group: ClinicalTrial
<http://ctro/data#ClinicalTrial_85390> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#ClinicalTrial> .
<http://ctro/data#ClinicalTrial_85390> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalTrial " .
<http://ctro/data#ClinicalTrial_85390> <http://ctro/data#hasObjectiveDescription> "To evaluate the efficacy and safety of adding the once - weekly DPP - 4 inhibitor omarigliptin or the sulfonylurea glimepiride to the treatment regimen of patients with type 2 diabetes ( T2DM ) and inadequate glycemic control on metformin monotherapy ." .
<http://ctro/data#ClinicalTrial_85390> <http://ctro/data#hasCTduration> "54 weeks" .
<http://ctro/data#AllocationRatio_85394> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio> .
<http://ctro/data#CTAnalysisApproach_85395> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTAnalysisApproach> .
<http://ctro/data#ClinicalTrial_85390> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized> .
<http://ctro/data#ClinicalTrial_85390> <http://ctro/data#hasConclusionComment> "After 54 weeks , as add - on therapy to metformin , once - weekly omarigliptin was generally well tolerated and non - inferior to glimepiride in improving glycemic control , with a lower incidence of hypoglycemia and with weight loss vs weight gain ." .
<http://ctro/data#ClinicalTrial_85390> <http://ctro/data#hasArm> <http://ctro/data#Arm_85454> .
<http://ctro/data#ClinicalTrial_85390> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes> .
<http://ctro/data#ClinicalTrial_85390> <http://ctro/data#hasPopulation> <http://ctro/data#Population_85408> .
<http://ctro/data#ClinicalTrial_85390> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_85539> .
<http://ctro/data#EvidenceQuality_85402> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EvidenceQuality> .
<http://ctro/data#ClinicalTrial_85390> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind> .
<http://ctro/data#CTDesign_85407> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTDesign> .
<http://ctro/data#ClinicalTrial_85390> <http://ctro/data#hasCTDesign> <http://ctro/data#CTDesign_85407> .
<http://ctro/data#ClinicalTrial_85390> <http://ctro/data#hasArm> <http://ctro/data#Arm_85476> .
# RDF export of group: Population
<http://ctro/data#Population_85408> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Population> .
<http://ctro/data#Population_85408> <http://www.w3.org/2000/01/rdf-schema#label> "Population " .
<http://ctro/data#Population_85408> <http://ctro/data#hasPrecondition> "Patients with T2DM and HbA1c ≥ 6 . 5 % to ≤ 9 . 0 % while on a stable dose of metformin ( ≥ 1500   mg / day )" .
<http://ctro/data#Ethnicity_85410> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Ethnicity> .
<http://ctro/data#Population_85408> <http://ctro/data#hasCountry> <http://ctro/data#USA> .
<http://ctro/data#Gender_85415> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Gender> .
# RDF export of group: Endpoint
<http://ctro/data#Endpoint_85416> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_85416> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint hba1c" .
<http://ctro/data#Endpoint_85416> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c> .
<http://ctro/data#Endpoint_85416> <http://ctro/data#hasAggregationMethod> <http://ctro/data#LeastSquaresMean> .
<http://ctro/data#Endpoint_85416> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage> .
<http://ctro/data#MeasurementDevice_85420> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_85421> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_85421> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint sh" .
<http://ctro/data#Endpoint_85421> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#SymptomaticHypoglycemia> .
<http://ctro/data#AggregationMethod_85423> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_85424> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_85425> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_85426> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_85426> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint h" .
<http://ctro/data#Endpoint_85426> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Hypoglycemia> .
<http://ctro/data#AggregationMethod_85428> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_85429> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_85430> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_85431> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_85431> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint aes" .
<http://ctro/data#EndPointDescription_85432> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription> .
<http://ctro/data#Endpoint_85431> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_85432> .
<http://ctro/data#AggregationMethod_85433> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_85434> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_85435> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_85436> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_85436> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint weight" .
<http://ctro/data#Endpoint_85436> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#BodyWeight> .
<http://ctro/data#Mean_85438> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean> .
<http://ctro/data#Endpoint_85436> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_85438> .
<http://ctro/data#Endpoint_85436> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Kg> .
<http://ctro/data#MeasurementDevice_85440> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
# RDF export of group: Arm
<http://ctro/data#Arm_85454> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_85454> <http://www.w3.org/2000/01/rdf-schema#label> "Arm o " .
<http://ctro/data#Arm_85454> <http://ctro/data#hasNumberPatientsArm> "376" .
<http://ctro/data#Arm_85454> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_85448> .
<http://ctro/data#Arm_85454> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_85485> .
<http://ctro/data#Arm_85454> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_85548> .
<http://ctro/data#Arm_85454> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_85602> .
<http://ctro/data#Arm_85454> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_85629> .
<http://ctro/data#Arm_85454> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_85656> .
<http://ctro/data#Arm_85476> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_85476> <http://www.w3.org/2000/01/rdf-schema#label> "Arm g" .
<http://ctro/data#Arm_85476> <http://ctro/data#hasNumberPatientsArm> "375" .
<http://ctro/data#Arm_85476> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_85470> .
<http://ctro/data#Arm_85476> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_85512> .
<http://ctro/data#Arm_85476> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_85575> .
<http://ctro/data#Arm_85476> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_85602> .
<http://ctro/data#Arm_85476> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_85629> .
<http://ctro/data#Arm_85476> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_85683> .
# RDF export of group: Intervention
<http://ctro/data#Intervention_85448> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_85448> <http://www.w3.org/2000/01/rdf-schema#label> "Intervention o " .
<http://ctro/data#Intervention_85448> <http://ctro/data#hasMedication> <http://ctro/data#Medication_85441> .
<http://ctro/data#Intervention_85448> <http://ctro/data#hasFrequency> "once - weekly" .
<http://ctro/data#RelativeTime_85453> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
<http://ctro/data#Intervention_85470> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_85470> <http://www.w3.org/2000/01/rdf-schema#label> "Intervention g" .
<http://ctro/data#Intervention_85470> <http://ctro/data#hasMedication> <http://ctro/data#Medication_85463> .
<http://ctro/data#Intervention_85470> <http://ctro/data#hasFrequency> "once daily" .
<http://ctro/data#RelativeTime_85475> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
# RDF export of group: Medication
<http://ctro/data#Medication_85441> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_85441> <http://www.w3.org/2000/01/rdf-schema#label> "Medication o" .
<http://ctro/data#Medication_85441> <http://ctro/data#hasDrug> <http://ctro/data#Omarigliptin> .
<http://ctro/data#Medication_85441> <http://ctro/data#hasDoseValue> "25" .
<http://ctro/data#Medication_85441> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg> .
<http://ctro/data#DeliveryMethod_85445> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
<http://ctro/data#Medication_85463> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_85463> <http://www.w3.org/2000/01/rdf-schema#label> "Medication g" .
<http://ctro/data#Medication_85463> <http://ctro/data#hasDrug> <http://ctro/data#Glimepiride> .
<http://ctro/data#Medication_85463> <http://ctro/data#hasDoseValue> "6   mg" .
<http://ctro/data#Medication_85463> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg> .
<http://ctro/data#DeliveryMethod_85467> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
<http://ctro/data#Medication_85463> <http://ctro/data#hasDoseDescription> "up to 6   mg once daily" .
# RDF export of group: Outcome
<http://ctro/data#Outcome_85485> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_85485> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome hba1c o" .
<http://ctro/data#Outcome_85485> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_85416> .
<http://ctro/data#Outcome_85485> <http://ctro/data#hasBaselineValue> "7 . 5" .
<http://ctro/data#Outcome_85485> <http://ctro/data#hasChangeValue> "0 . 30" .
<http://ctro/data#Outcome_85512> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_85512> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome g" .
<http://ctro/data#Outcome_85512> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_85416> .
<http://ctro/data#Outcome_85512> <http://ctro/data#hasBaselineValue> "7 . 4" .
<http://ctro/data#Outcome_85512> <http://ctro/data#hasChangeValue> "0 . 48" .
<http://ctro/data#Outcome_85548> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_85548> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome sh o " .
<http://ctro/data#Outcome_85548> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_85421> .
<http://ctro/data#Outcome_85548> <http://ctro/data#hasPercentageAffected> "5 . 3" .
<http://ctro/data#Outcome_85575> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_85575> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome sh g" .
<http://ctro/data#Outcome_85575> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_85421> .
<http://ctro/data#Outcome_85575> <http://ctro/data#hasPercentageAffected> "26 . 7" .
<http://ctro/data#Outcome_85602> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_85602> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome h both drugs" .
<http://ctro/data#Outcome_85602> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_85426> .
<http://ctro/data#Outcome_85602> <http://ctro/data#hasObservedResult> "With the exception of hypoglycemia , the incidences of adverse events and discontinuations were similar between treatment groups" .
<http://ctro/data#Outcome_85629> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_85629> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome aes both drugs" .
<http://ctro/data#Outcome_85629> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_85431> .
<http://ctro/data#Outcome_85629> <http://ctro/data#hasObservedResult> "With the exception of hypoglycemia , the incidences of adverse events and discontinuations were similar between treatment groups" .
<http://ctro/data#Outcome_85656> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_85656> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome weight o " .
<http://ctro/data#Outcome_85656> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_85436> .
<http://ctro/data#Outcome_85656> <http://ctro/data#hasChangeValue> "0 . 4" .
<http://ctro/data#Outcome_85683> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_85683> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome weight g" .
<http://ctro/data#Outcome_85683> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_85436> .
<http://ctro/data#Outcome_85683> <http://ctro/data#hasChangeValue> "1 . 5" .
# RDF export of group: DiffBetweenGroups
<http://ctro/data#DiffBetweenGroups_85539> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_85539> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups hba1c " .
<http://ctro/data#DiffBetweenGroups_85539> <http://ctro/data#hasDiffGroupAbsValue> "0 . 18" .
<http://ctro/data#DiffBetweenGroups_85539> <http://ctro/data#hasConfIntervalDiff> "95 % CI" .
<http://ctro/data#DiffBetweenGroups_85539> <http://ctro/data#hasConfIntervalDiff> "0 . 06 , 0 . 30" .
<http://ctro/data#DiffBetweenGroups_85539> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_85485> .
<http://ctro/data#DiffBetweenGroups_85539> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_85512> .
# RDF export of group: EvidenceQuality